Back to library
Performance EnhancementResearch

Cardarine (GW-501516)

kar-da-reen

Research profile · How we handle evidence

Category

Performance Enhancement

Compound type

Phase / Status

Research

Research chemical. Not FDA approved. Development halted due to cancer concerns in animal studies at very high doses. Widely used in research settings.

Standard Dose

10-20mg daily

Once daily

Half-life

12-24 hours

Plasma elimination

Route(s)

OR

Oral

Research Stage

Status Unknown

Research phase not specified; exercise appropriate caution.

Overview

Cardarine is like having an extra lung. It shifts your body from burning glucose to burning fat for fuel, which means insane endurance and rapid fat loss. It's not a SARM and won't mess with your testosterone or estrogen. No PCT needed. Popular with endurance athletes but banned in all sports. Animal studies showed cancer risk at mega doses, so don't be stupid with dosing. Keep it moderate.

Plain-language summary

Cardarine is like having an extra lung. It shifts your body from burning glucose to burning fat for fuel, which means insane endurance and rapid fat loss. It's not a SARM and won't mess with your testosterone or estrogen. No PCT needed. Popular with endurance athletes but banned in all sports. Animal studies showed cancer risk at mega doses, so don't be stupid with dosing. Keep it moderate.

Administration Routes

  • Oral

Also known as

CardarineGW-501516GWthe endurance drug

Mechanisms

1

PPAR-delta receptor agonist - alters energy metabolism to preferentially burn fatty acids instead of glucose. Basically tells your muscles to use fat as fuel instead of sugar.

Detailed mechanism

PPAR-delta receptor agonist that shifts energy metabolism from glucose to fatty acids, increasing endurance and fat oxidation without affecting hormonal pathways.

Safety

Side effects

  • Potential cancer risk concerns in animal studies (high doses)
  • Mild suppression of HDL cholesterol
  • Possible liver stress with extended use
  • Headache in some users
  • GI discomfort

Reported benefits

  • Dramatic endurance and stamina increase
  • Serious fat loss without muscle loss
  • Improved cardiovascular health markers
  • Faster recovery between sets
  • Zero testosterone suppression
  • No PCT required

Safety profile

Controversial safety profile. Animal studies show cancer risk at very high doses. Human data limited. Not approved for human use.

Clinical trials

Phase 1/2 trials completed but development halted due to cancer concerns in mice at extremely high doses. Human data limited.

Structure

View 3D structure

Verified structure

Cardarine (GW-501516)

Exact 2D structure can be rendered from a PubChem-backed canonical SMILES string.

Verified via PubChemMatched by casNumber
Source: PubChemLookup: 317318-70-0InChIKey YDBLKRPLXZNVNB-UHFFFAOYSA-N
Chemical Formula
C21H18F3NO3S2
Molecular Weight
453.5 g/mol
CAS Number
317318-70-0
InChIKey
YDBLKRPLXZNVNB-UHFFFAOYSA-N

Stack Context

Stacks with

OstarineLigandrolStenabolic

Comparison context

Cardarine dramatically improves endurance and fat oxidation through PPAR-delta activation, while SR-9009 (Stenabolic) does the same through Rev-ErbA agonism, both boost cardio but through different mechanisms. Unlike clenbuterol, which burns fat through beta-2 agonism and comes with jitters, cardarine is smooth and non-stimulating. AICAR also activates AMPK for endurance but through a completely different pathway.

References

  1. 1

    Cardarine (GW501516) improves metabolic syndrome

    2011

    View source
  2. 2

    PPAR-delta in exercise and metabolism

    2017

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.